US-listed drug stocks slipped. BioNTech (BNTX.O) fell 11%, its largest intraday decline since March 10, after the company said it would terminate a Phase II colorectal cancer trial. Moderna (MRNA.O) dropped 5% and Merck (MRK.N) fell 1.3%.

The PBOC and the Financial Regulatory Administration may, within their respective mandates and as warranted by economic and social development, introduce new real-estate loan products.

Li Chao, deputy director of the policy research office at the CHINA STATE PLANNER, told the agency's August briefing the so‑called "China squeeze" argument is a baseless zero‑sum attack aimed at preserving hegemonic interests and denying other countries' development rights. He said China is supporting industrialization and green transition in developing countries through concrete actions, that imports and exports with over 180 countries and regions rose in the first seven months of the year, and pledged China will continue to contribute to global development and human progress.